Concurrent cyclophosphamide (CTX), mediastinal radiotherapy (MXRT), and other factors increasing the risk of adriamycin (A) induced cardiomyopathy (CMY)

R. A. Minow, R. S. Benjamin, J. A. Gottlieb

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Concurrent cyclophosphamide (CTX), mediastinal radiotherapy (MXRT), and other factors increasing the risk of adriamycin (A) induced cardiomyopathy (CMY)'. Together they form a unique fingerprint.